Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
21 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sobi-has-completed-issues-of-class-c-shares-302535718.html
25 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tryngolza-olezarsen-recommended-for-eu-approval-by-chmp-for-familial-chylomicronemia-syndrome-fcs-302513906.html
25 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/25/3121718/0/en/Sobi-Announces-U-S-Food-and-Drug-Administration-Approves-Doptelet-avatrombopag-for-the-Treatment-of-Thrombocytopenia-in-Pediatric-Patients-One-Year-and-Older-with-Persistent-or-Chr.html
16 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sobi-publishes-q2-2025-report-continued-strong-portfolio-and-pipeline-momentum-302506522.html
15 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-board-of-directors-of-sobi-exercises-authorisation-for-repurchase-of-shares-for-the-purpose-of-securing-the-companys-commitments-under-incentive-programmes-302505893.html
02 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/invitation-sobis-q2-report-302496717.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE